Transcranial Magnetic Stimulation (TMS) is one of the fastest growing therapies in Psychiatry. Earn CME credits while learning about the latest advances including new applications pending FDA approval.
This course, which was developed by leading clinicians and researchers, provides practical, up-to-date information to Psychiatrists, Physicians and allied health professionals who are interested in the clinical use of TMS (transcranial magnetic stimulation).
Course content will address the science underlying the mechanism of action of TMS, the data demonstrating the efficacy of TMS in treatment-resistant major depressive disorder, and the evidence for the safety of TMS. Additional topics will address practical issues of patient selection, initial treatment planning, patient management during and after an acute course of TMS therapy, and the use of standardized measures to assess patient outcome. The development of TMS technology and TMS coil design will be reviewed. Practical administration of TMS in a clinical setting and insurance reimbursement for TMS will be discussed. Data regarding the efficacy of TMS in the treatment of neuropsychiatric disorders other than depression will be reviewed along with new developments in TMS and other emerging brain stimulation and neuromodulation technologies.
Finally, participants will have the opportunity to gain hands-on experience with TMS devices currently cleared for clinical use by the FDA.
The presentational method for this activity will be Case Presentation with Learner Participation, Panel Discussion, Lecture with Q&A, Small Group Discussion/Roundtable, Hands-On Demonstration (with TMS Devices), and Simulated or live Patient. This live course is geared towards Physicians and Allied Health Personnel interested in the administration of TMS for depression. This activity will encompass the following desirable physician attributes: Patient Care & Procedural Skills, Medical Knowledge, Professionalism, Practice-Based Learning & Improvement, and Systems-Based Practice.
At the end of the activity, participants should be able to:
- Explain the mechanism of action of TMS
- Identify appropriate patients for TMS
- Identify the risks and side effects of TMS
- Manage patients during TMS
- Define the role of the TMS treater in TMS
- Identify and manage common TMS complications
- Define the requirements for setting up a clinical TMS service
- Identify cultural factors related to patient selection
The CME Institute of Physicians Postgraduate Press, Inc., designates this enduring material for a maximum of 25.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The CME Institute of Physicians Postgraduate Press, Inc., and TMS Health Solutions. The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the ACCME to provide continuing medical education for physicians
Thursday, August 16th – Sunday, August 19th, 2018
Course Price: $2,995
Residents and Technician Price: $1,995
This activity has been approved for 25.5 AMA PRA Category 1 Credits™
Faculty at the Symposium has acclaimed teaching credentials from universities and facilities such as the Mayo Clinic, Stanford, Northwestern University and UCLA.
The conference will be held at the
Grand Hyatt San Francisco: Union Square